Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivatives.

[1]  M. Heravi,et al.  Recent Advances in the Application of the Sonogashira Method in the Synthesis of Heterocyclic Compounds , 2009 .

[2]  David G. I. Kingston,et al.  Tubulin-interactive natural products as anticancer agents. , 2008, Journal of natural products.

[3]  H. Hsieh,et al.  Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors. , 2008, Journal of medicinal chemistry.

[4]  Anurag Chaudhary,et al.  Combretastatin a-4 analogs as anticancer agents. , 2007, Mini reviews in medicinal chemistry.

[5]  C. Nájera,et al.  The Sonogashira reaction: a booming methodology in synthetic organic chemistry. , 2007, Chemical reviews.

[6]  R. Gambari,et al.  Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents. , 2006, Journal of medicinal chemistry.

[7]  Giovanni Sorba,et al.  Medicinal chemistry of combretastatin A4: present and future directions. , 2006, Journal of medicinal chemistry.

[8]  H. Hsieh,et al.  Antitubulin agents for the treatment of cancer – a medicinal chemistry update , 2006 .

[9]  J. D. de Bono,et al.  Update on tubulin-binding agents. , 2006, Pathologie-biologie.

[10]  E. Pasquier,et al.  Understanding microtubule dynamics for improved cancer therapy , 2005, Cellular and Molecular Life Sciences CMLS.

[11]  D. Budman,et al.  Review: Tubulin Function, Action of Antitubulin Drugs, and New Drug Development , 2005, Cancer investigation.

[12]  L. Amos,et al.  Microtubule structure and its stabilisation. , 2004, Organic & biomolecular chemistry.

[13]  M. Jordan,et al.  Microtubules as a target for anticancer drugs , 2004, Nature Reviews Cancer.

[14]  N. Nam.  Combretastatin A-4 analogues as antimitotic antitumor agents. , 2003, Current medicinal chemistry.

[15]  N. Lawrence,et al.  Structural requirements for the interaction of combretastatins with tubulin: how important is the trimethoxy unit? , 2003, Organic & biomolecular chemistry.

[16]  C. Walczak.  Microtubule dynamics and tubulin interacting proteins. , 2000, Current opinion in cell biology.

[17]  M. Boyd,et al.  Antineoplastic agents. 379. Synthesis of phenstatin phosphate. , 1998, Journal of medicinal chemistry.

[18]  M. Cushman,et al.  Synthesis and evaluation of analogues of (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents. , 1992, Journal of medicinal chemistry.

[19]  E. Hamel,et al.  Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin. , 1989, Biochemistry.

[20]  D. Alberts,et al.  Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4 , 1989, Experientia.

[21]  C. Lozzio,et al.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.

[22]  B. Hearn,et al.  Microtubule Targeting Agents , 2007 .

[23]  E. Hamel.  Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin , 2007, Cell Biochemistry and Biophysics.

[24]  W. Gerwick,et al.  Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells. , 1998, Molecular pharmacology.